...
首页> 外文期刊>Angewandte Chemie >A Convergent, Enantioselective Total Synthesis of Hapalosin: A Drug with Multidrug-Resistance Reversing Activity
【24h】

A Convergent, Enantioselective Total Synthesis of Hapalosin: A Drug with Multidrug-Resistance Reversing Activity

机译:Hapalosin的收敛,对映选择性的全合成:具有多药耐药逆转活性的药物。

获取原文
获取原文并翻译 | 示例
           

摘要

Hapalosin (1), a novel cyclodepsipeptide isolated recently from the blue-green alga Hapalosiphon welwitschii, has shown important multidrug-resistance reversing activity. The term multidrug-resistance (MDR), is defined us ihe ability of tumor cells exposed to one drug to develop eross resistance to seemingly unrelated drugs. This phenomenon is apparently caused by an overexpression of P-glycoprotein, a 170-200 kDa transmembrane, protein that acts as an ATP-dependent drug efflux pump. As a consequence, chemotherap) very often becomes ineffective.
机译:Hapalosin(1)是最近从蓝绿藻Hapalosiphon welwitschii中分离出的一种新型环二肽,已显示出重要的多药耐药逆转活性。术语多药耐药性(MDR)是指暴露于一种药物的肿瘤细胞对看似无关的药物产生抵抗力的能力。这种现象显然是由P-糖蛋白(一种170-200 kDa的跨膜蛋白)的过表达引起的,该蛋白起着ATP依赖性药物外排泵的作用。结果,化学疗法常常变得无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号